3 unchanged sentences
CONSOLIDATED CONDENSED BALANCE SHEETS AS OF
−Removed: JUNE 30, 2023 AND DECEMBER 31, 2022
+Added: SEPTEMBER 30, 2023 AND DECEMBER 31, 2022
(in thousands)
−Removed: JUNE 30, 2023
+Added: SEPTEMBER 30, 2023
DECEMBER 31, 2022
21 unchanged sentences
authorized - 50,000 shares;
−Removed: issued and outstanding - June 30, 2023, 3,629 shares and December 31, 2022, 3,628 shares
−Removed: Accumulated other comprehensive loss
+Added: issued - September 30, 2023, 3,629 shares and December 31, 2022, 3,628 shares
+Added: Accumulated other comprehensive income (loss)
Additional paid-in capital
6 unchanged sentences
CONSOLIDATED CONDENSED STATEMENTS OF INCOME FOR THE
−Removed: THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND JUNE 30, 2022
+Added: THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND SEPTEMBER 30, 2022
(in thousands, except per share amounts - unaudited)
Three Months Ended
−Removed: Six Months Ended
−Removed: June 30, 2023
−Removed: June 30, 2022
−Removed: June 30, 2023
−Removed: June 30, 2022
+Added: Nine Months Ended
+Added: September 30, 2023
+Added: September 30, 2022
+Added: September 30, 2023
+Added: September 30, 2022
Cost of goods sold
2 unchanged sentences
Research & development
−Removed: Total operating expenses
+Added: Total operating expense
Operating income
12 unchanged sentences
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
−Removed: FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND JUNE 30, 2022
+Added: FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND SEPTEMBER 30, 2022
(in thousands - unaudited)
−Removed: Six Months Ended
+Added: Nine Months Ended
+Added: September 30,
CASH FLOWS FROM OPERATING ACTIVITIES:
33 unchanged sentences
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY FOR THE
−Removed: THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022
+Added: THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND SEPTEMBER 30, 2022
(In thousands - unaudited)
1 unchanged sentence
Stockholders'
−Removed: Income (Loss)
−Removed: Balance at December 31, 2022
+Added: Balance at June 30, 2023
Shares issued upon exercise of employee
3 unchanged sentences
Common stock dividends
−Removed: Balance at March 31, 2023
+Added: Balance at September 30, 2023
+Added: Balance at December 31, 2022
Shares issued upon exercise of employee
3 unchanged sentences
Common stock dividends
+Added: Balance at September 30, 2023
Balance at June 30, 2022
−Removed: Balance at December 31, 2021
Shares issued upon exercise of employee
3 unchanged sentences
Common stock dividends
−Removed: Balance at March 31, 2022
+Added: Balance at September 30, 2022
+Added: Balance at December 31, 2021
Shares issued upon exercise of employee
4 unchanged sentences
Common stock dividends
−Removed: Balance at June 30, 2022
+Added: Balance at September 30, 2022
see notes to consolidated condensed financial statements
8 unchanged sentences
(2) Recent Accounting Standards.
−Removed: The Company has determined that recently issued accounting standards will either have no material impact on its consolidated financial position or results of operations or cash flows, or will not apply to its operations.
−Removed: (3) Inventories at June 30, 2023 and December 31, 2022 consisted of the following:
−Removed: June 30, 2023
+Added: The Company has determined that other recently issued accounting standards will either have no material impact on its consolidated financial position, results of operations or cash flows, or will not apply to its operations.
+Added: (3) Inventories at September 30, 2023, and December 31, 2022, consisted of the following:
+Added: September 30, 2023
December 31, 2022
3 unchanged sentences
(4) Stock-Based Compensation.
−Removed: At June 30, 2023, the Company has stock-based employee compensation plans which authorize the grant of stock options to eligible employees and directors.
+Added: At September 30, 2023, the Company has stock-based employee compensation plans which authorize the grant of stock options to eligible employees and directors.
The Company accounts for stock compensation under FASB Accounting Standards Codification (“ASC”) 718, Compensation - Stock Compensation .
This statement requires the Company to recognize compensation cost based on the grant date fair value of options granted to employees and directors.
−Removed: In the quarters ended June 30, 2023 and 2022, the Company recognized $ 50 and $ 40 , respectively, in stock based compensation cost.
−Removed: In the six months ended June 30, 2023 and 2022, the Company recognized $ 100 and $ 83 , respectively, in stock based compensation cost.
+Added: In the quarters ended September 30, 2023, and 2022, the Company recognized $ 53 and $ 38 , respectively, in stock based compensation cost.
+Added: In the nine months ended September 30, 2023, and 2022, the Company recognized $ 153 and $ 121 , respectively, in stock based compensation cost.
(5) Warranty Reserve.
4 unchanged sentences
The amount of this reserve is adjusted, as required, to reflect its actual experience.
−Removed: Based on its analysis of historical warranty claims and its estimate that existing warranty obligations were immaterial, no warranty reserve was made at December 31, 2022 or June 30, 2023.
+Added: Based on its analysis of historical warranty claims and its estimate that existing warranty obligations were immaterial, no warranty reserve was made at December 31, 2022, or September 30, 2023.
(6) Global 3Q 2023 revenues (USD) by product category:
+Added: Labor & Delivery
Gynecology/Electrosurgery/Urology
Blood Pressure Monitoring and Accessories
−Removed: Global 1H 2023 revenues (USD) by product category:
+Added: Global 9M 2023 revenues (USD) by product category:
+Added: Labor & Delivery
Gynecology/Electrosurgery/Urology
3 unchanged sentences
distribution rights for the Filshie Clip System from CooperSurgical, Inc.
−Removed: (CSI) on February 1, 2019.
−Removed: The $ 21,000 purchase price represented an identifiable intangible asset which is being straight-line amortized and recognized as part of G&A expenses over a remaining 4 -month life as of June 30, 2023 of the prior CSI distribution agreement with Femcare.
+Added: (CSI) as of February 1, 2019.
+Added: The $ 21,000 purchase price represented an identifiable intangible asset which is being straight-line amortized and recognized as part of G&A expenses over a remaining one month of life as of September 30, 2023 of the prior CSI distribution agreement with Femcare Ltd.
(8) Earnings Per Share.
Basic earnings per share is calculated by dividing net income attributable to the common stockholders of the company by the weighted average number of common shares outstanding during the period.
−Removed: Diluted earnings per share is calculated by assuming the exercise of stock options at the closing price of stock on June 30, 2023.
+Added: Diluted earnings per share is calculated by assuming the exercise of stock options at the closing price of stock at the end of 3rd quarter 2023.
The following table reconciles the numerator and the denominator used to calculate basic and diluted earnings per share:
1 unchanged sentence
Three months ended
−Removed: Six months ended
+Added: Nine months ended
+Added: September 30,
+Added: September 30,
Weighted average shares, basic
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.